Anti-NGF Antibody Pain Relief Involves Changes in Endogenous Opioid Peptide Systems

Anti-nerve growth factor immunoglobulin-induced pain relief was partly mediated through enhanced endogenous opioid peptide signaling, linking NGF antagonism to the opioid pain control system.

Hoffman, E M et al.·Neuroscience·2011·
RPEP-017802011RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Anti-nerve growth factor immunoglobulin-induced pain relief was partly mediated through enhanced endogenous opioid peptide signaling, linking NGF antagonism to the opioid pain control system.

Key Numbers

How They Did This

research study.

Why This Research Matters

Relevant for peptide research.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.

Trust & Context

Key Stat:
Key finding Anti-nerve growth factor immunoglobulin-induced pain relief was partly mediated through enhanced endogenous opioid peptide signaling, linking NGF anta
Evidence Grade:
emerging evidence.
Study Age:
Published in 2011.
Original Title:
Potential mechanisms for hypoalgesia induced by anti-nerve growth factor immunoglobulin are identified using autoimmune nerve growth factor deprivation.
Published In:
Neuroscience, 193, 452-65 (2011)
Database ID:
RPEP-01780

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

Anti-NGF Antibody Pain Relief Involves Changes in Endogenous Opioid Peptide Systems

What was found?

Anti-nerve growth factor immunoglobulin-induced pain relief was partly mediated through enhanced endogenous opioid peptide signaling, linking NGF antagonism to the opioid pain control system.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01780·https://rethinkpeptides.com/research/RPEP-01780

APA

Hoffman, E M; Zhang, Z; Anderson, M B; Schechter, R; Miller, K E. (2011). Potential mechanisms for hypoalgesia induced by anti-nerve growth factor immunoglobulin are identified using autoimmune nerve growth factor deprivation.. Neuroscience, 193, 452-65. https://doi.org/10.1016/j.neuroscience.2011.06.069

MLA

Hoffman, E M, et al. "Potential mechanisms for hypoalgesia induced by anti-nerve growth factor immunoglobulin are identified using autoimmune nerve growth factor deprivation.." Neuroscience, 2011. https://doi.org/10.1016/j.neuroscience.2011.06.069

RethinkPeptides

RethinkPeptides Research Database. "Potential mechanisms for hypoalgesia induced by anti-nerve g..." RPEP-01780. Retrieved from https://rethinkpeptides.com/research/hoffman-2011-potential-mechanisms-for-hypoalgesia

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.